In light of controversy over the recent semaglutide drug shortages for the diabetes patients they're indicated for, one doctor illuminates another side of the case. From the Kardashians to that person ...

GLP-1 weight loss drugs — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — work by suppressing appetite and delaying the rate at which your stomach empties.

J. Cameron StewartAlamogordo News The Rock It, Rocket that is opening in November is undergoing a series of much needed upgrades down on New York… ...

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more effective until now. But the jabs have gone head-to-head in an effectiveness ...

Ozempic is the brand name for semaglutide, which is the active ingredient in several weight loss medications. Semaglutide is known as a 'GLP-1 receptor agonist' which is a drug that imitates your ...

For the study, researchers followed 262 adults who were prescribed GLP-1 medications like semaglutide or liraglutide ... were cutting back on alcohol's empty calories. "The significance of this ...

First off, it’s important to note that the moniker is misleading. Ozempic, a specific brand of the drug semaglutide, often gets used as the shorthand for all GLP-1s – primarily because it’s ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review the ...

Between January and mid-May 2024, some 2,780 reports of spontaneous suspected adverse drug reactions to semaglutide were reported to the UK's Medicines and Healthcare products Regulatory Agency.

The 61st annual PEN America Literary Awards were held May 8 at the Town Hall in midtown Manhattan, awarding nearly $350,000 in prizes to writers, editors, and translators at a ceremony hosted by ...

The findings strengthen the case for GLP-1s as an addiction treatment, the researchers say. Semaglutide (the active ingredient in Ozempic and Wegovy) and similar GLP-1 drugs are far more effective ...

Semaglutide shows promise in MASH treatment, achieving significant MASH resolution and fibrosis improvement in the ESSENCE trial. Tolerability issues and insurance coverage challenges lead to 20% ...